Melanoma: open trials in Japan

8 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT07492680
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
National Cancer Center Hospital, Chuo Ku
Registry updated 2026-11-04
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Chuo Ku · Kashiwa
Registry updated 2026-11-03
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Saitama Medical University International Medical Center, Hidaka · HAKUAIKAI Social Medical Corporation Sagara Hospital, Kagoshima · Kanagawa Cancer Center, Kanagawa · National Cancer Center Hospital East, Kashiwa-shi · NHO Shikoku Cancer Center, Matsuyama · Shizuoka Cancer Center, Nagaizumi-chō · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Osakasayama-Shi · Saitama Cancer Center, Saitama · National Cancer Center Hospital, Tokyo · Showa Medical University Hospital, Tokyo · Cancer Institute Hospital of JFCR, Tokyo · Yokohama City University Medical Center, Yokohama
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, Kashiwa · The Cancer Institute Hospital of JFCR, Koto-ku · National Hospital Organization Shikoku Cancer Center, Matsuyama · Shizuoka Cancer Center, Nagaizumi-chō · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Ōsaka-sayama · Saitama Cancer Center, Saitama
Registry updated 2026-10-26
NCT05423262
A Study of TRK-950 in Patients With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Toray Industries, Inc
National Cancer Center Hospital, Chuo Ku · National Hospital Organization Kyushu Cancer Center, Fukuoka · Saitama Medical University International Medical Center, Hidaka · Kumamoto University Hospital, Kumamoto · Shinshu University Hospital, Matsumoto · Shizuoka Cancer Center, Nagaizumi-chō · Nagoya City University Hospital, Nagoya · Niigata Cancer Center Hospital, Niigata · Sapporo Medical University Hospital, Sapporo · Keio University Hospital, Shinjuku-ku
Registry updated 2026-10-08
NCT07115043
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · AstraZeneca
Chūōku · Kashiwa
Registry updated 2026-10-08
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
National Cancer Center Hospital East, Kashiwa
Registry updated 2026-08-17
NCT06636435
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Trial Treatment · Phase 1 · Chiome Bioscience Inc.
University of Yamanashi Hospital, Chūō · National Cancer Center Hospital, Chūō · National Cancer Center Hospital East, Kashiwa · Niigata University Medical and Dental Hospital, Niigata · Kanagawa Cancer Center, Yokohama
Registry updated 2026-06-17

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error